Investing

Vanda Pharmaceuticals : VNDA

VNDA

Stock Data

$7.00

$0.10 (1.41%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vanda Pharmaceuticals Inc is a biopharmaceutical company dedicated to creating treatments for a variety of health conditions with unmet medical needs around the globe. It markets HETLIOZ for non-24-hour sleep-wake disorders and Fanapt for schizophrenia. The company is also developing treatments for conditions like jet lag, insomnia, bipolar I disorder, and Parkinson’s disease psychosis, among others. Additionally, Vanda is working on therapies for gastroparesis, motion sickness, and certain dermatological and respiratory conditions. Founded in 2002, Vanda is based in Washington, D.C.

All Vanda Pharmaceuticals Articles

28 Articles

Chris Lange | Feb 25, 2022 at 11:31 AM EST

Friday Afternoon’s Top Analyst Upgrades and Downgrades: BP, Carvana, Iron Mountain, Latch, LivePerson and More

Friday afternoon's top analyst upgrades and downgrades included BP, Carvana, Iron Mountain, Latch and LivePerson.

Chris Lange | May 12, 2021 at 12:02 PM EDT

Amazon, Caterpillar, Disney, EA, Target and More Wednesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Amazon, Caterpillar,…

Chris Lange | Dec 2, 2020 at 9:11 AM EST

Vanda Investors Can Sleep Easy With This FDA Approval

Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime…

Chris Lange | Aug 18, 2020 at 10:40 AM EDT

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.

Jon C. Ogg | Jun 9, 2020 at 9:14 AM EDT

Top Analyst Upgrades and Downgrades: Avaya, Biogen, Broadcom, Chevron, Domino’s, eBay, MGIC, RealReal, Sprout Social, T-Mobile, Zoom, Zynga and More

Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile,…

Chris Lange | Aug 19, 2019 at 8:55 AM EDT

Why the FDA Is a Little Slow on This Jet Lag Study

Vanda Pharma shares dropped early to start out the week after the frim announced that it received a Complete Response…

Jon C. Ogg | Aug 1, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify, Western Digital, Whiting Petroleum and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Allstate, Corning, DexCom, Lam Research, On Deck, Qualcomm, Spotify,…

Jon C. Ogg | Jul 25, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Caterpillar, Dollar General, EA, Etsy, Facebook, Spirit Airlines, Tesla, Xilinx and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AT&T, Caterpillar, Dollar General, Electronic Arts, Etsy, Facebook, Spirit…

Jon C. Ogg | Feb 6, 2019 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq,…

Jon C. Ogg | Dec 4, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Abbott Labs, Apple, Apptio, Cheniere, First Solar, Kratos, Smartsheet, UPS, Waste Management and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Apple, Apptio, Cheniere Energy, First Solar, Kratos…

Chris Lange | Dec 3, 2018 at 9:50 AM EST

Vanda Pharma Nails Midstage Gastroparesis Study

Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients…

Jon C. Ogg | Oct 30, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under…

Jon C. Ogg | Jun 27, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess…

Lee Jackson | Jan 10, 2017 at 8:35 AM EST

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. The question for investors is which of the…

Lee Jackson | Oct 12, 2016 at 9:55 AM EDT

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

Jefferies highlights top growth stocks to buy each week, and this week is no exception. These four all make good…